Preliminary results show the device, created at Cedars-Sinai and developed by NeuroVision Imaging, may provide highly predictive early detection of changes associated with Alzheimer’s disease
A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer’s disease, according to preliminary results from investigators conducting a clinical trial in Australia.
The researchers will present their findings July 15 in an oral presentation at the Alzheimer’s Association International Conference 2014 in Copenhagen, Denmark. They also were invited by conference organizers to participate in a “breaking news” news conference beginning at 7:30 a.m. Sunday, July 13 in Copenhagen, 1:30 a.m. EDT.
“In preliminary results in 40 patients, the test could differentiate between Alzheimer’s disease and non-Alzheimer’s disease with 100 percent sensitivity and 80.6 percent specificity, meaning that all people with the disease tested positive and most of the people without the disease tested negative. The optical imaging exam appears to detect changes that occur 15-20 years before clinical diagnosis. It’s a practical exam that could allow testing of new therapies at an earlier stage, increasing our chances of altering the course of Alzheimer’s disease,” said Shaun Frost, a biomedical scientist and the study manager at the Commonwealth Scientific and Industrial Research Organisation. CSIRO is Australia’s national science agency.
The Latest on: Alzheimer’s testing
[google_news title=”” keyword=”Alzheimer’s testing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s testing
- Wendy Williams diagnosed with primary progressive aphasia and frontotemporal dementiaon February 23, 2024 at 6:35 am
Wendy Williams' team revealed she has been diagnosed with primary progressive aphasia and frontotemporal dementia.
- Study shows a frontline Alzheimer’s blood test could be as accurate as spinal fluid examson February 23, 2024 at 2:40 am
Researchers at the Washington University in St. Louis and Lund University in Sweden have taken a step closer toward developing a blood test that could be used during an annual doctor’s office visit to ...
- Blood test rivals spinal fluid analysis in Alzheimer's detectionon February 22, 2024 at 7:53 pm
tests in detecting Alzheimer's disease (AD) pathology, utilizing the BioFINDER-2 and Knight Alzheimer Disease Research Center (ADRC) cohorts. Study: Highly Accurate Blood Test for Alzheimer’s Disease ...
- An MCU test chip embeds 10.8 Mbit STT-MRAM memoryon February 22, 2024 at 4:01 pm
A prototype MCU test chip with a 10.8 Mbit magnetoresistive random-access memory (MRAM) memory cell array—fabricated on a 22-nm embedded MRAM process—claims to accomplish a random read access ...
- Alzheimer's blood test found to perform as well as FDA-approved spinal fluid testson February 22, 2024 at 8:05 am
A simple blood test to diagnose Alzheimer's disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.
- Wendy Williams, like Bruce Willis, has frontotemporal dementia. What is FTD?on February 21, 2024 at 11:15 pm
The 59-year-old former talk show host was diagnosed last year with with primary progressive aphasia and frontotemporal dementia “after undergoing a battery of medical tests,” according to the ...
- Nectar Premier Copper Mattress Review 2024: A Cooling Memory Foam Bed Put to the Teston February 20, 2024 at 4:00 pm
Interested in a premium memory foam mattress from a reputable online brand that also sleeps on the cooler side? In this review, I'll cover all that and more, including who this bed should work best ...
- Embic Preps for Explosion in Alzheimer’s Testson February 18, 2024 at 4:00 pm
The Newport Beach-based provider of cognitive tests has benefited from a recent Food and Drug Administration approval for a new drug to treat Alzheimer’s disease. “This whole space was stagnant,” ...
- OpenAI Tests Stronger ChatGPT Memory: Here's What It'll Remember About Youon February 17, 2024 at 4:00 am
ChatGPT maker OpenAI is testing a version of its chatbot that remembers what users tell it. ChatGPT can even use that information in subsequent conversations, the company said Tuesday. Not all users ...
- Test screening for 11 blood biomarkers could predict dementia 15 years sooneron February 16, 2024 at 7:30 am
Researchers are devising a blood test screening for 11 newly discovered biomarkers of dementia. They say the test could predict its development 15 years before symptom onset.
via Bing News